Who will be the winner in the new drug challenge of the KRW 2.6 trillion xerophthalmia market?
Aim for the xerophthalmia market. Domestic pharmaceutical companies have made challenges to new xerophthalmia drugs in the global market.
Although no product has been commercialized, products of the pharmaceutical companies are evaluated to make huge impacts once they are launched.
Challenges o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
